CD44 and small cell lung carcinoma: As MSCs possess the potential to promote metastasis by downregulating antitumor immune responses [35, 36], the presence of CD44+ SCLC cells was of abundance and in close contact with lymphocytes in the metastatic lymph nodes although they were scarce in primary tumors.